Completed OBSERVATIONAL NCT04387786

Dornase Alfa Administered to Patients With COVID-19 (DACOVID) (DACOVID)

Nebulized In-line Endotracheal Dornase Alfa and Albuterol Administered to Mechanically Ventilated COVID-19 Patients: A Case Series

Sponsor: Cold Spring Harbor Laboratory

Conditions COVID-19 Mechanical Ventilation

Interventions Dornase Alfa

Updated 5 times since 2020 Last updated: Nov 12, 2020 Started: Mar 31, 2020 Primary completion: Apr 24, 2020 Completion: Sep 4, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on COVID-19 and Mechanical Ventilation, this trial is completed. The trial is conducted by Cold Spring Harbor Laboratory and has accumulated 5 data snapshots since 2020. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Dec 2020 — Jan 2021 [monthly]

Completed

Status: Active Not Recruiting → Completed
Jun 2020 — Dec 2020 [monthly]

Active Not Recruiting

First recorded

Mar 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cold Spring Harbor Laboratory
Feinstein Institute for Medical Research

Data source: Northwell Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Manhasset, United States